Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 366,905 | 1,640,151 | 1,399,329 | 855,869 | 386,527 |
| Depreciation Amortization | 468,016 | 2,040,032 | 1,407,468 | 892,956 | 442,038 |
| Income taxes - deferred | -7,299 | 126,914 | 16,857 | 48,261 | -32,292 |
| Accounts receivable | -579,320 | 81,897 | 21,712 | -61,099 | -280,928 |
| Accounts payable and accrued liabilities | 7,519 | -18,632 | 20,307 | 19,449 | 16,257 |
| Other Working Capital | -469,047 | 1,411,269 | 1,597,075 | 1,454,063 | -112,450 |
| Other Operating Activity | 463,565 | -446,097 | -197,101 | -12,654 | 225,191 |
| Operating Cash Flow | $250,340 | $4,835,534 | $4,265,647 | $3,196,844 | $644,343 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -215,712 | -1,183,885 | -859,781 | -546,834 | -309,484 |
| Net Acquisitions | -126,164 | -279,152 | -166,519 | -106,035 | -35,082 |
| Purchase Of Investment | -12,947 | -110,119 | -35,241 | N/A | N/A |
| Sale Of Investment | 84,704 | 48,252 | 32,127 | N/A | N/A |
| Investing Cash Flow | $-270,118 | $-1,524,904 | $-1,029,414 | $-652,869 | $-344,566 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,290,632 | 907,931 | 927,160 | 758,755 | 1,140,570 |
| Debt Issued | 11,686 | 2,422,710 | 2,465,739 | 1,392,036 | 13,971 |
| Debt Repayment | -1,070,832 | -1,811,937 | -1,800,901 | -1,168,153 | -627,333 |
| Common Stock Issued | 693 | 14,454 | 12,235 | 10,327 | 458 |
| Common Stock Repurchased | N/A | -418,068 | -427,840 | -402,989 | -238,427 |
| Dividend Paid | -83,817 | -819,540 | -410,518 | N/A | N/A |
| Other Financing Activity | -191,661 | -3,338,668 | -3,215,443 | -2,134,049 | -155,406 |
| Financing Cash Flow | $-43,299 | $-3,043,118 | $-2,449,568 | $-1,544,073 | $133,834 |
| Exchange Rate Effect | 53,359 | -183,192 | -95,860 | -29,051 | 4,723 |
| Beginning Cash Position | 1,303,903 | 1,151,122 | 1,178,028 | 1,109,604 | 1,111,720 |
| End Cash Position | 1,294,185 | 1,235,442 | 1,868,832 | 2,080,455 | 1,550,053 |
| Net Cash Flow | $-9,718 | $84,320 | $690,804 | $970,851 | $438,333 |
| Free Cash Flow | |||||
| Operating Cash Flow | 250,340 | 4,835,534 | 4,265,647 | 3,196,844 | 644,343 |
| Capital Expenditure | -222,193 | -1,201,680 | -871,617 | -550,735 | -311,077 |
| Free Cash Flow | 28,147 | 3,633,854 | 3,394,030 | 2,646,109 | 333,266 |